Primary Site >> Colorectal Cancer

Gene >> RBM39

  • 2009
  • 2011
  • 2012
Ref: The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients.
PMID: 19956169
 Ref: The diagnostic performance of scoring systems to identify symptomatic colorectal cancer compared to current referral guidance.
PMID: 21357592
 Ref: TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
PMID: 22207630
Ref: CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
PMID: 22711543